42.58

1.12% -0.46

Castle Biosciences Inc (CSTL)

Overview News Price History Option Chain Financials Why CSTL Down? Discussions Forecast

Castle Biosciences Inc stock is traded at $42.58, with a volume of 180.04K. It is down -1.12% in the last 24 hours and up +8.03% over the past month. Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Previous Close:

$43.04

Open:

$43

24h Volume:

180.04K

Relative Volume:

0.45

Market Cap:

$1.24B

Revenue:

$219.79M

Net Income/Loss:

$-57.47M

P/E Ratio:

-19.80

EPS:

-2.15

Net Cash Flow:

$-19.25M

1W Performance:

+4.16%

1M Performance:

+8.03%

6M Performance:

+164.84%

1Y Performance:

+59.70%

1-Day Range:

$42.39

$43.24

1-Week Range:

$40.33

$44.28

52-Week Range:

$14.59

$44.28

Castle Biosciences Inc Stock (CSTL) Company Profile

Name

Castle Biosciences Inc

Sector

Healthcare (1119)

Industry

Diagnostics & Research (52)

Phone

866-788-9007

Address

505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX

Employee

823

Twitter

@castlebio

Next Earnings Date

2024-11-04

Latest SEC Filings

CSTL's Discussions on Twitter

Compare CSTL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CSTL Castle Biosciences Inc	42.55	1.26B	219.79M	-57.47M	-19.25M	-2.15
TMO Thermo Fisher Scientific Inc	624.75	235.43B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	235.35	167.20B	24.27B	3.50B	5.02B	4.8589
IDXX Idexx Laboratories Inc	697.90	55.72B	4.17B	1.03B	940.22M	12.61
IQV Iqvia Holdings Inc	241.86	40.77B	15.90B	1.28B	2.21B	7.2842
A Agilent Technologies Inc	135.71	38.46B	6.95B	1.30B	1.15B	4.5696

Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-14-23	Initiated	Guggenheim	Buy
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-07-22	Initiated	Stephens	Overweight
Apr-30-21	Initiated	Lake Street	Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Dec-27-19	Reiterated	Canaccord Genuity	Buy
Aug-19-19	Initiated	BTIG Research	Buy
Aug-19-19	Initiated	Canaccord Genuity	Buy
Aug-19-19	Initiated	Robert W. Baird	Outperform
Aug-19-19	Initiated	SVB Leerink	Outperform

View All

Castle Biosciences Inc Stock (CSTL) Latest News

Jan 26, 2026

The Analyst Verdict: Castle Biosciences In The Eyes Of 7 Experts - Benzinga

Jan 26, 2026

Jan 25, 2026

Are you looking for a top momentum pick? Why Castle Biosciences, Inc. (CSTL) is a great choice - MSN

Jan 25, 2026

Jan 24, 2026

Aug Outlook: How sensitive is Castle Biosciences Inc to inflationMarket Risk Report & Entry Point Strategy Guides - baoquankhu1.vn

Jan 24, 2026

AIGH Capital Management LLC Acquires New Position in Castle Biosciences, Inc. $CSTL - MarketBeat

Jan 24, 2026

Jan 23, 2026

Are You Looking for a Top Momentum Pick? Why Castle Biosciences, Inc. (CSTL) is a Great Choice - Yahoo Finance

Jan 23, 2026